Swiss wealth manager Julius Baer is launching its Biotech fund to UK investors.
Launched on 31 January 2008, the Julius Baer Biotech fund's euro share class returned 4.75% in its first full year. The fund focuses on companies which develop products and technology for four sectors - healthcare, agricultural, food science and environmental. Managed by Eric Bernhardt and Nathalie Flury, the fund plays on the fact investment in biotech in the US - where this fund focus most of its portfolio - trebled between 1996 and 2008. Biotech beat the broader indices in 2008 - the S&P500 lost around 40% over the year, while the Nasdaq Biotechnology Index declined by 12%. Bernh...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes